Quick Answer
Cue Biopharma, Inc. reported Common Stock Shares Outstanding of 96.62 million shares for the year ending 2025.
- Cue Biopharma, Inc. showed an increase of +56.3% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Cue Biopharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: 20.13 million shares | Q2 2018: 20.13 million shares | Q3 2018: 20.13 million shares | Q1 2019: 20.78 million shares | Q2 2019: 21.31 million shares | Q3 2019: 22.97 million shares | Q1 2020: 26.58 million shares | Q2 2020: 29.30 million shares | Q3 2020: 30.25 million shares | Q1 2021: 30.50 million shares | Q2 2021: 31.47 million shares | Q3 2021: 31.36 million shares | Q1 2022: 34.17 million shares | Q2 2022: 35.38 million shares | Q3 2022: 35.39 million shares | Q1 2023: 43.18 million shares | Q2 2023: 43.74 million shares | Q3 2023: 45.12 million shares | Q1 2024: 48.64 million shares | Q2 2024: 48.64 million shares | Q3 2024: 60.21 million shares | Q1 2025: 61.82 million shares | Q2 2025: 76.45 million shares | Q3 2025: 77.78 million shares.
- Over the full 9 years of available data (2017 to 2025), Cue Biopharma, Inc.'s Common Stock Shares Outstanding has grown by 396.5%.
- Historical annual values: Fiscal year 2025: 96.62 million shares | Fiscal year 2024: 61.82 million shares | Fiscal year 2023: 47.22 million shares | Fiscal year 2022: 47.22 million shares | Fiscal year 2021: 32.20 million shares | Fiscal year 2020: 30.35 million shares | Fiscal year 2019: 26.56 million shares | Fiscal year 2018: 20.70 million shares | Fiscal year 2017: 19.46 million shares.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: